Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

M Solmi, M De Toffol, JY Kim, MJ Choi, B Stubbs… - bmj, 2023 - bmj.com
Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …

Cannabis-based products for chronic pain: a systematic review

MS McDonagh, BJ Morasco, J Wagner… - Annals of internal …, 2022 - acpjournals.org
Background: Contemporary data are needed about the utility of cannabinoids in chronic
pain. Purpose: To evaluate the benefits and harms of cannabinoids for chronic pain. Data …

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process

A Bhaskar, A Bell, M Boivin, W Briques… - Journal of cannabis …, 2021 - Springer
Background Globally, medical cannabis legalization has increased in recent years and
medical cannabis is commonly used to treat chronic pain. However, there are few …

Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory …

D Haspula, MA Clark - International journal of molecular sciences, 2020 - mdpi.com
The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …

Medical cannabis treatment for chronic pain: outcomes and prediction of response

J Aviram, D Pud, T Gershoni… - … Journal of Pain, 2021 - Wiley Online Library
Background Although studied in a few randomized controlled trials, the efficacy of medical
cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this …

Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials

I Dykukha, R Malessa, U Essner, MA Überall - Pain Medicine, 2021 - academic.oup.com
Objective Pooled analysis of nabiximols and placebo in randomized controlled studies
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …

[HTML][HTML] Cannabis and pain: a scoping review

C Pantoja-Ruiz, P Restrepo-Jimenez… - Brazilian Journal of …, 2022 - SciELO Brasil
For centuries, cannabis has been used with many different purposes, including medicinal
use, usually bypassing any formal approval process. However, during the last decade …

Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

E Sokolaj, N Assareh, K Anderson… - Journal of …, 2023 - Wiley Online Library
Chronic neuropathic pain is a debilitating pain syndrome caused by damage to the nervous
system that is poorly served by current medications. Given these problems, clinical studies …

Cannabis and orofacial pain: a systematic review

S Grossman, H Tan, Y Gadiwalla - British Journal of Oral and Maxillofacial …, 2022 - Elsevier
The naturally occurring cannabis plant has played an established role in pain management
throughout recorded history. However, in recent years, both natural and synthetic cannabis …

Cannabinoid use and effects in patients with epidermolysis bullosa: An international cross-sectional survey study

NHB Schräder, ES Gorell, RE Stewart… - Orphanet journal of rare …, 2021 - Springer
Background Epidermolysis bullosa (EB) patient anecdotes and case reports indicate that
cannabinoid-based medicines (CBMs) may alleviate pain and pruritus and improve wound …